Wellocity Health offers a SaaS platform for digital therapeutics where customers can brand, deliver, scale, and adapt programs to the needs of patients and employers. The HIPAA Compliant Wellocity platform powers virtual delivery for digital therapeutics programs, including the CDC-led National DPP lifestyle change program to increase access, improve outcomes, and make the best use of a limited supply of lifestyle coaches.
Wellocity Health platform selected by the National Association of Community Health Centers (NACHC) to power nationwide program
To improve diabetes control among health center patients while also tackling diabetes prevention
SAN FRANCISCO (PRWEB) OCTOBER 13, 2021
Wellocity, a San Jose-based provider of a platform for digital therapeutics programs, today announced that it was selected from a national pool of applicants for an RFP issued by the National Association of Community Health Centers (NACHC). Wellocity will be designing and managing a platform to power a nationwide program to improve diabetes control among health center patients while also tackling diabetes prevention.
Inspiring Communities Partners with Wellocity Health to Deliver National DPP Online
Online delivery provides convenient access to participants from anywhere at any time to fit within a busy lifestyle
SAN FRANCISCO (PRWEB) JANUARY 20, 2021
Inspiring Communities, a nonprofit organization based in Richmond, CA with full CDC recognition for delivering in-person National Diabetes Prevention Program (National DPP), has partnered with Wellocity Health to deliver the National DPP online in English and Spanish. Online delivery provides convenient access to participants from anywhere at any time via their mobile device or computer to fit within a busy lifestyle to prevent type 2 diabetes.
Wellocity Health Announces Appointment of New Advisors
To accelerate the growth of Wellocity’s Telehealth platform for Disease Prevention Programs
SAN FRANCISCO (PRWEB) DECEMBER 17, 2020
Wellocity Health, a Telehealth platform company that powers the delivery of Digital Therapeutics Programs for evidence-based personalized lifestyle change focused on preventing diabetes and heart disease, recently announced the addition of two new advisors. Alon Gitig, M.D., F.A.C.C., a Preventive Cardiologist and Medical Director at Mount Sinai Health System, and Elizabeth Hawk MS, RDN, CDE at Penn State Health St. Joseph, have joined Wellocity’s advisory board.